Overview
Maurice Cairoli is an Oncologist and a Hematologist in Mount Holly, New Jersey. Dr. Cairoli is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Virilizing Ovarian Tumor. Dr. Cairoli is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
175 Madison Ave, Mount Holly, NJ 08060
Medical Oncology Hematology Consultants PA
Jamal Misleh is a Hematologist Oncology specialist and a Hematologist in Newark, Delaware. Dr. Misleh is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Neuroendocrine Tumor, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Misleh is currently accepting new patients.
Abington Memorial Hospital
Christian Fidler is a Hematologist Oncology specialist and a Hematologist in Willow Grove, Pennsylvania. Dr. Fidler is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Neuroendocrine Tumor, Mast Cell Activation Syndrome (MCAS), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Large-Cell Immunoblastic Lymphoma.
Regional Cancer Care Associates LLC
Rachel Levenbach is an Oncologist and a Hematologist in Mount Holly, New Jersey. Dr. Levenbach is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Paget Disease of the Breast, Neuroendocrine Tumor, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Levenbach is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Cairoli isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Cairoli isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Cairoli isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Cairoli isAdvanced. Learn about Angiosarcoma.
- Colorectal CancerDr. Cairoli isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Cairoli isAdvanced. Learn about Familial Colorectal Cancer.
- Non-Hodgkin LymphomaDr. Cairoli isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Ovarian CarcinosarcomaDr. Cairoli isAdvanced. Learn about Ovarian Carcinosarcoma.
- Pleuropulmonary BlastomaDr. Cairoli isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Cairoli isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Cairoli isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Cairoli isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Cairoli isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.